Oritavancin compared against vancomycin for skin infections

09/10/2013 | SkinAndAllergyNews.com

The effectiveness of single-dose intravenous oritavancin was similar to that of seven- to 10-day treatment with intravenous vancomycin for acute bacterial skin and skin structure infections, a multicenter study found. The most common adverse events reported in the oritavancin group included nausea, diarrhea and headache. Oritavancin was "well-tolerated, with a safety profile similar to vancomycin," lead author Dr. G. Ralph Corey reported at the Interscience Conference on Antimicrobial Agents and Chemotherapy.

View Full Article in:

SkinAndAllergyNews.com

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Corporate Counsel - Regulatory Law
Regeneron
Tarrytown, NY
ISHN - Chief Compliance Officer
Mountain States Health Alliance
Johnson City, TN
Active Implantable Medical Device (AIMD) Product Expert
BSI
Nationwide, SL_Nationwide
Finance Manager - ENT
Medtronic
Jacksonville, FL
Consumer Directed Health Plan (CDH) Product Offering Manager
Blue Cross Blue Shield MA
Quincy, MA